CD 130 (Ranitidine Hydrochloride 300 mg)
Pill with imprint CD 130 is Brown, Capsule-shape and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Dr. Reddy’s Laboratories Inc..
Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; gerd; duodenal ulcer prophylaxis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CD 130
Ranitidine Hydrochloride
- Imprint
- CD 130
- Strength
- 300 mg
- Color
- Brown
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- Inactive Ingredients
-
magnesium stearate, microcrystalline cellulose, sodium starch glycolate type A potato, ferrosoferric oxide, ferric oxide red, ferric oxide yellow, titanium dioxide, gelatin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 55111-0130 | Dr. Reddy's Laboratories, Inc. |
| 42291-0736 | AvKare, Inc. |
Related Images for "CD 130"
More about ranitidine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 152 Reviews
- Drug class: H2 antagonists
- FDA Alerts (18)
Consumer resources
- Ranitidine
- Ranitidine Injection
- Ranitidine Suspension
- Ranitidine Syrup
- Ranitidine Tablets and Capsules
Other brands: Zantac
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
